SBHMY
Price
$18.65
Change
+$1.15 (+6.57%)
Updated
Jul 28 closing price
Capitalization
16.62B
SYBX
Price
$1.36
Change
-$0.02 (-1.45%)
Updated
Aug 7 closing price
Capitalization
15.92M
Interact to see
Advertisement

SBHMY vs SYBX

Header iconSBHMY vs SYBX Comparison
Open Charts SBHMY vs SYBXBanner chart's image
Sino Biopharmaceutical
Price$18.65
Change+$1.15 (+6.57%)
Volume$1.03K
Capitalization16.62B
Synlogic
Price$1.36
Change-$0.02 (-1.45%)
Volume$3.22K
Capitalization15.92M
SBHMY vs SYBX Comparison Chart in %
Loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SBHMY vs. SYBX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Buy and SYBX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (SBHMY: $18.65 vs. SYBX: $1.36)
Brand notoriety: SBHMY and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 299% vs. SYBX: 6%
Market capitalization -- SBHMY: $16.62B vs. SYBX: $15.92M
SBHMY [@Biotechnology] is valued at $16.62B. SYBX’s [@Biotechnology] market capitalization is $15.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 3 FA rating(s) are green whileSYBX’s FA Score has 1 green FA rating(s).

  • SBHMY’s FA Score: 3 green, 2 red.
  • SYBX’s FA Score: 1 green, 4 red.
According to our system of comparison, SBHMY is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBHMY’s TA Score shows that 1 TA indicator(s) are bullish while SYBX’s TA Score has 4 bullish TA indicator(s).

  • SBHMY’s TA Score: 1 bullish, 3 bearish.
  • SYBX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SYBX is a better buy in the short-term than SBHMY.

Price Growth

SBHMY (@Biotechnology) experienced а 0.00% price change this week, while SYBX (@Biotechnology) price change was -11.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($16.6B) has a higher market cap than SYBX($15.9M). SBHMY has higher P/E ratio than SYBX: SBHMY (63.82) vs SYBX (6.19). SBHMY YTD gains are higher at: 128.675 vs. SYBX (-2.793). SBHMY has higher annual earnings (EBITDA): 6.89B vs. SYBX (-13.66M). SBHMY has higher revenues than SYBX: SBHMY (28.9B) vs SYBX (0).
SBHMYSYBXSBHMY / SYBX
Capitalization16.6B15.9M104,403%
EBITDA6.89B-13.66M-50,483%
Gain YTD128.675-2.793-4,607%
P/E Ratio63.826.191,032%
Revenue28.9B0-
Total CashN/A17.3M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
SBHMY vs SYBX: Fundamental Ratings
SBHMY
SYBX
OUTLOOK RATING
1..100
3686
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
2746
PRICE GROWTH RATING
1..100
3547
P/E GROWTH RATING
1..100
729
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (3) in the null industry is significantly better than the same rating for SYBX (86) in the Biotechnology industry. This means that SBHMY’s stock grew significantly faster than SYBX’s over the last 12 months.

SBHMY's Profit vs Risk Rating (100) in the null industry is in the same range as SYBX (100) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's SMR Rating (27) in the null industry is in the same range as SYBX (46) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's Price Growth Rating (35) in the null industry is in the same range as SYBX (47) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's P/E Growth Rating (7) in the null industry is in the same range as SYBX (29) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBHMYSYBX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
38%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
33%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
33%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
36%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WD79.914.43
+5.87%
Walker & Dunlop
EONR0.290.01
+5.09%
EON Resources Inc
PHM120.670.44
+0.37%
Pultegroup
EVLV6.98-0.14
-1.97%
Evolv Technologies Holdings
ARBE1.28-0.09
-6.57%
Arbe Robotics Ltd

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
-2.13%
SYBX - SBHMY
34%
Loosely correlated
-1.38%
BTAI - SBHMY
32%
Poorly correlated
+2.71%
CLRPF - SBHMY
24%
Poorly correlated
-10.09%
VIVS - SBHMY
20%
Poorly correlated
-2.40%
More